Pricing Log in Create free account

CERo Therapeutics Holdings, Inc. (CERO) vs Vincerx Pharma, Inc. (VINC)

CERo Therapeutics Holdings, Inc. and Vincerx Pharma, Inc. are both Biotechnology companies. Vincerx Pharma, Inc. is the larger, with a market value of $250.0K against $140.0K — 1.8× the size. Across the 9 metrics below, CERo Therapeutics Holdings, Inc. leads on 7 and Vincerx Pharma, Inc. on 2.

Valuation

Metric CERO VINC Biotechnology median
P/E n/m n/m 10.60
P/S n/m n/m 9.40
P/B n/m 0.03 2.13
Price to free cash flow n/m n/m 25.18
EV/EBITDA 0.00 0.17 0.66
EV/Sales n/m n/m 9.02
Earnings yield 0.00% (46,330.00%) (32.88%)
Free cash flow yield 0.00% (32,262.57%) (23.13%)

Profitability

Metric CERO VINC Biotechnology median
Gross margin — 0.00% 68.51%
Operating margin 0.00% 0.00% 0.00%
Net margin 0.00% 0.00% 0.00%
Free cash flow margin 0.00% 0.00% 0.00%
Return on equity 453.76% (3,136.43%) (51.96%)
Return on assets (2,352.32%) (287.21%) (46.06%)
Return on invested capital 0.00% 0.00% 0.00%

Growth

Metric CERO VINC Biotechnology median
Revenue growth (TTM) — — 6.76%
EPS growth (last fiscal year) 99.91% 58.07% 29.88%
Revenue growth, 5-year CAGR — — 9.75%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric CERO VINC Biotechnology median
Debt to equity (0.02) 0.00 0.00
Current ratio 0.05 1.79 4.97
Net debt to EBITDA 0.10 0.17 1.01

Dividend

Metric CERO VINC Biotechnology median
Dividend yield — — 0.41%
Payout ratio — — —

Size

Metric CERO VINC Biotechnology median
Market cap 140.00k 250.00k 161.82m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack